Cancer in COVID-19 Times – A Narrative Review of Guidelines and Recommendations
Journal of Medical and Radiation Oncology · 2021
DOI: 10.53011/jmro.2021.01.11 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Medical and Radiation Oncology, 2021. Verfasst von Alecsandra Gorzo und 1 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
"Coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first reported to produce atypical pneumonia in Wuhan, China, in December 2019. This outbreak escalated very quickly due to the high transmission rate, and therefore, on March 11, 2020, it was declared a pandemic by the World Health Organization. COVID-19 caused a massive hospital overload worldwide and instigated urgent adjustments in resource allocation. Compared to the general population, cancer patients are considered to be at high risk of developing severe infection due to their immunocompromised status. The purpose of this review was to highlight the impact of the COVD-19 pandemic on cancer care, available guidelines, and recommendations."
Zitieren
APA
Gorzo, A., & Sur, D. (2021). Cancer in COVID-19 Times – A Narrative Review of Guidelines and Recommendations. Journal of Medical and Radiation Oncology. https://doi.org/10.53011/jmro.2021.01.11
Vancouver
Gorzo A, Sur D. Cancer in COVID-19 Times – A Narrative Review of Guidelines and Recommendations. Journal of Medical and Radiation Oncology. 2021. doi:10.53011/jmro.2021.01.11
BibTeX
@article{Gorzo2021,
author = {Gorzo, Alecsandra and Sur, Daniel},
title = {Cancer in COVID-19 Times – A Narrative Review of Guidelines and Recommendations},
journal = {Journal of Medical and Radiation Oncology},
year = {2021},
doi = {10.53011/jmro.2021.01.11}
}
EUVIMED